StockNews.com Begins Coverage on Mannatech (NASDAQ:MTEX)

Equities research analysts at StockNews.com started coverage on shares of Mannatech (NASDAQ:MTEX – Get Rating) in a research note issued on Tuesday. The brokerage set a “buy” rating on the stock.

Separately, TheStreet upgraded Mannatech from a “c+” rating to a “b-” rating in a report on Thursday, October 13th.

Mannatech Price Performance

Shares of NASDAQ:MTEX opened at $16.24 on Tuesday. Mannatech has a one year low of $15.49 and a one year high of $38.30. The stock has a fifty day moving average of $19.79 and a 200-day moving average of $20.56. The company has a market capitalization of $30.19 million, a PE ratio of 7.19 and a beta of 1.17. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.74 and a current ratio of 1.27.

Mannatech (NASDAQ:MTEX – Get Rating) last announced its quarterly earnings data on Tuesday, November 8th. The company reported $0.61 EPS for the quarter. Mannatech had a return on equity of 20.94% and a net margin of 3.24%. The company had revenue of $35.51 million during the quarter.

Insider Buying and Selling

In related news, Director Kevin Andrew Robbins sold 1,500 shares of the stock in a transaction on Thursday, December 8th. The stock was sold at an average price of $22.00, for a total transaction of $33,000.00. Following the completion of the sale, the director now directly owns 11,531 shares in the company, valued at $253,682. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, CEO Alfredo Bala sold 3,500 shares of the stock in a transaction on Wednesday, December 21st. The stock was sold at an average price of $19.69, for a total transaction of $68,915.00. Following the completion of the sale, the chief executive officer now directly owns 4,406 shares in the company, valued at $86,754.14. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Kevin Andrew Robbins sold 1,500 shares of the stock in a transaction on Thursday, December 8th. The stock was sold at an average price of $22.00, for a total transaction of $33,000.00. Following the transaction, the director now directly owns 11,531 shares in the company, valued at $253,682. The disclosure for this sale can be found here. 50.00% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Mannatech

An institutional investor recently raised its position in Mannatech stock. LSV Asset Management boosted its holdings in shares of Mannatech, Incorporated (NASDAQ:MTEX – Get Rating) by 1,090.3% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,142 shares of the company’s stock after buying an additional 6,542 shares during the quarter. LSV Asset Management owned about 0.37% of Mannatech worth $261,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 24.90% of the company’s stock.

Mannatech Company Profile

(Get Rating)

Mannatech, Inc engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L.